chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: swollen; super itchy; red; Injection site swelling; Injection site pain; redness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (swollen), PRURITUS (super itchy), ERYTHEMA (red), INJECTION SITE SWELLING (Injection site swelling) and INJECTION SITE PAIN (Injection site pain) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical reported history).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (Injection site swelling), INJECTION SITE PAIN (Injection site pain) and INJECTION SITE ERYTHEMA (redness). On 28-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen), PRURITUS (super itchy) and ERYTHEMA (red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH STOPPING CREAM) for Itching, at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Swelling, at an unspecified dose and frequency. On 24-Jan-2021, INJECTION SITE SWELLING (Injection site swelling), INJECTION SITE PAIN (Injection site pain) and INJECTION SITE ERYTHEMA (redness) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen), PRURITUS (super itchy) and ERYTHEMA (red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (tested positive to antibodies in 28-NOV-2020) in March 2020.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vaccination site pain, Vomiting
Clinical narrative: sore arm; headache that started at night; nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), HEADACHE (headache that started at night), NAUSEA (nausea) and VOMITING (Vomiting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 025J20A) for COVID-19 vaccination.     No medical history information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm), NAUSEA (nausea) and VOMITING (Vomiting). 08-Feb-2021, the patient experienced HEADACHE (headache that started at night). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 325 milligram and BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at a dose of 262 milligram. At the time of the report, VACCINATION SITE PAIN (sore arm), NAUSEA (nausea) and VOMITING (Vomiting) was resolving and HEADACHE (headache that started at night) had not resolved.            No concomitant drugs were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site mass
Clinical narrative: Knot at injection site; Red at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE MASS (Knot at injection site) and VACCINATION SITE ERYTHEMA (Red at injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028l20a) for COVID-19 vaccination.     Concomitant products included FISH OIL, POTASSIUM, HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]), OMEPRAZOLE and CALCIUM for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 07-Feb-2021, the patient experienced VACCINATION SITE MASS (Knot at injection site) and VACCINATION SITE ERYTHEMA (Red at injection site). On 29-Jan-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VACCINATION SITE MASS (Knot at injection site) and VACCINATION SITE ERYTHEMA (Red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was treated with topical cortisone and ibuprofen.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; chills; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) from 14-Jan-2021 to 15-Jan-2021 for Fever, at an unspecified dose and frequency and IBUPROFEN on 14-Jan-2021 at an unspecified dose and frequency. On 15-Jan-2021, PYREXIA (fever) and CHILLS (chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Peripheral swelling, Vaccination complication, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Hot red mark that is spreading; Inflamed arm; swollen arm; covid arm; Hot red mark that is spreading; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot red mark that is spreading), INFLAMMATION (Inflamed arm), PERIPHERAL SWELLING (swollen arm), VACCINATION COMPLICATION (covid arm) and VACCINATION SITE ERYTHEMA (Hot red mark that is spreading) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot red mark that is spreading), INFLAMMATION (Inflamed arm), PERIPHERAL SWELLING (swollen arm), VACCINATION COMPLICATION (covid arm) and VACCINATION SITE ERYTHEMA (Hot red mark that is spreading). At the time of the report, VACCINATION SITE WARMTH (Hot red mark that is spreading), INFLAMMATION (Inflamed arm), PERIPHERAL SWELLING (swollen arm), VACCINATION COMPLICATION (covid arm) and VACCINATION SITE ERYTHEMA (Hot red mark that is spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Arm broke out / arm red; Arm broke out / arm itches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Arm broke out / arm itches) and RASH ERYTHEMATOUS (Arm broke out / arm red) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN, CLOPIDOGREL BISULFATE, PANTOPRAZOLE SODIUM and LISINOPRIL for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced RASH PRURITIC (Arm broke out / arm itches). On 31-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Arm broke out / arm red). On 31-Jan-2021, RASH PRURITIC (Arm broke out / arm itches) had resolved. At the time of the report, RASH ERYTHEMATOUS (Arm broke out / arm red) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Exfoliative rash, Rash, Rash papular, Rash pruritic
Clinical narrative: Scaling type pruritic papular rash; Scaling type pruritic papular rash; Scaling type pruritic papular rash; Rash all over her body; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXFOLIATIVE RASH (Scaling type pruritic papular rash), RASH PRURITIC (Scaling type pruritic papular rash), RASH PAPULAR (Scaling type pruritic papular rash) and RASH (Rash all over her body) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced EXFOLIATIVE RASH (Scaling type pruritic papular rash), RASH PRURITIC (Scaling type pruritic papular rash), RASH PAPULAR (Scaling type pruritic papular rash) and RASH (Rash all over her body). The patient was treated with DIPHENHYDRAMINE HCL for Rash, at an unspecified dose and frequency. At the time of the report, EXFOLIATIVE RASH (Scaling type pruritic papular rash), RASH PRURITIC (Scaling type pruritic papular rash), RASH PAPULAR (Scaling type pruritic papular rash) and RASH (Rash all over her body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: continued dizziness and weakness; continued dizziness and weakness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (continued dizziness and weakness) and DIZZINESS (continued dizziness and weakness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (continued dizziness and weakness) and DIZZINESS (continued dizziness and weakness). At the time of the report, ASTHENIA (continued dizziness and weakness) and DIZZINESS (continued dizziness and weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Influenza like illness, Migraine
Clinical narrative: Migraine headache; Very tired; Flu like symptoms; Brain fog; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache), FEELING ABNORMAL (Brain fog), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Very tired) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced FEELING ABNORMAL (Brain fog). On 06-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 07-Feb-2021, the patient experienced FATIGUE (Very tired). On 09-Feb-2021, the patient experienced MIGRAINE (Migraine headache). The patient was treated with IBUPROFEN at a dose of 800 mg. At the time of the report, MIGRAINE (Migraine headache), FEELING ABNORMAL (Brain fog), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included ibuprofen.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Tachycardia
Clinical narrative: Heart rate elevated; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart rate elevated) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced TACHYCARDIA (Heart rate elevated). At the time of the report, TACHYCARDIA (Heart rate elevated) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Heart rate: 124 (High) Normal resting rate is 70. On 08-Feb-2021, Heart rate: 90 (High) 90-110 beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash, Vaccination site pain, Vaccination site warmth
Clinical narrative: Site was warm to touch; Patient experienced a rash; Fatigue; Mild pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Site was warm to touch), RASH (Patient experienced a rash), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Mild pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Site was warm to touch), RASH (Patient experienced a rash), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Mild pain). At the time of the report, VACCINATION SITE WARMTH (Site was warm to touch), RASH (Patient experienced a rash), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Mild pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Hyperhidrosis, Injection site erythema, Injection site pain
Clinical narrative: Hazy; Felt Weird; Sweating Profusely; Red; Sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red), INJECTION SITE PAIN (Sore), DIZZINESS (Hazy), FEELING ABNORMAL (Felt Weird) and HYPERHIDROSIS (Sweating Profusely) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Red) and INJECTION SITE PAIN (Sore). On 24-Jan-2021, the patient experienced DIZZINESS (Hazy), FEELING ABNORMAL (Felt Weird) and HYPERHIDROSIS (Sweating Profusely). On 25-Jan-2021, INJECTION SITE PAIN (Sore), DIZZINESS (Hazy), FEELING ABNORMAL (Felt Weird) and HYPERHIDROSIS (Sweating Profusely) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: potential side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE EVENT (potential side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE EVENT (potential side effect). At the time of the report, ADVERSE EVENT (potential side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain
Clinical narrative: Achy; Muscles hurt; Joints hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), MYALGIA (Muscles hurt) and ARTHRALGIA (Joints hurt) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced PAIN (Achy), MYALGIA (Muscles hurt) and ARTHRALGIA (Joints hurt). At the time of the report, PAIN (Achy), MYALGIA (Muscles hurt) and ARTHRALGIA (Joints hurt) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-043100.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: fatigue; drowsy; dizzy; weak; doesn't feel well; lost appetite; didn't sleep last night; muscle pain; don't feel comfortable; little pain (site of shot); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak) and MALAISE (doesn't feel well) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (doesn't feel well), DECREASED APPETITE (lost appetite), INSOMNIA (didn't sleep last night), MYALGIA (muscle pain), FEELING ABNORMAL (don't feel comfortable) and VACCINATION SITE PAIN (little pain (site of shot)). At the time of the report, FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (doesn't feel well), DECREASED APPETITE (lost appetite), INSOMNIA (didn't sleep last night), MYALGIA (muscle pain), FEELING ABNORMAL (don't feel comfortable) and VACCINATION SITE PAIN (little pain (site of shot)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Myalgia, Somnolence, Vaccination site pain
Clinical narrative: fatigue; drowsy; dizzy; weak; doesn't feel well; lost appetite; didn't sleep last night; muscle pain; don't feel comfortable; little pain (site of shot); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak) and MALAISE (doesn't feel well) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (doesn't feel well), DECREASED APPETITE (lost appetite), INSOMNIA (didn't sleep last night), MYALGIA (muscle pain), FEELING ABNORMAL (don't feel comfortable) and VACCINATION SITE PAIN (little pain (site of shot)). At the time of the report, FATIGUE (fatigue), SOMNOLENCE (drowsy), DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (doesn't feel well), DECREASED APPETITE (lost appetite), INSOMNIA (didn't sleep last night), MYALGIA (muscle pain), FEELING ABNORMAL (don't feel comfortable) and VACCINATION SITE PAIN (little pain (site of shot)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pyrexia, Swelling face
Clinical narrative: shortness of breath; Fever; puffed face; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), PYREXIA (Fever) and SWELLING FACE (puffed face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), PYREXIA (Fever) and SWELLING FACE (puffed face). At the time of the report, DYSPNOEA (shortness of breath), PYREXIA (Fever) and SWELLING FACE (puffed face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Vaccination complication
Clinical narrative: and then a couple of little ones after; Sharp pain in upper chest; Took breath away; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Sharp pain in upper chest), DYSPNOEA (Took breath away) and VACCINATION COMPLICATION (and then a couple of little ones after) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included QUINAPRIL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), METOPROLOL, OMEPRAZOLE and ATORVASTATIN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced CHEST PAIN (Sharp pain in upper chest) and DYSPNOEA (Took breath away). On an unknown date, the patient experienced VACCINATION COMPLICATION (and then a couple of little ones after). On 04-Feb-2021, CHEST PAIN (Sharp pain in upper chest) and DYSPNOEA (Took breath away) had resolved. At the time of the report, VACCINATION COMPLICATION (and then a couple of little ones after) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: swelling and redness on the area; swelling and redness on the area; itching on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching on the injection site), VACCINATION SITE ERYTHEMA (swelling and redness on the area) and VACCINATION SITE SWELLING (swelling and redness on the area) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching on the injection site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (swelling and redness on the area) and VACCINATION SITE SWELLING (swelling and redness on the area). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching on the injection site), VACCINATION SITE ERYTHEMA (swelling and redness on the area) and VACCINATION SITE SWELLING (swelling and redness on the area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.    This case was linked to MOD-2021-084525 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: No specific follow-up information recorded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Pallor
Clinical narrative: pale on the injection site; darker spot bruise on the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE BRUISING (darker spot bruise on the injection site) and PALLOR (pale on the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included DICYCLOMINE HCL, GABAPENTIN, FLECAINIDE, RIVAROXABAN (XARELTO) and LISINOPRIL for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced INJECTION SITE BRUISING (darker spot bruise on the injection site). On 31-Jan-2021, the patient experienced PALLOR (pale on the injection site). At the time of the report, INJECTION SITE BRUISING (darker spot bruise on the injection site) and PALLOR (pale on the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   .   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Follow Up done. symptoms of the event updated.concomitant medications were reported.the outcome of the event was mentioned to be resolving
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cold sweat, Feeling abnormal, Illness, Myalgia
Clinical narrative: weak; hurt in the back of her neck; cold sweats; feels like she was going to die; nauseated; threw up; body aches; sick all night; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick all night), COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), ASTHENIA (weak) and NECK PAIN (hurt in the back of her neck) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN A [RETINOL] and PROBIOTICS NOS for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (fever). On 06-Feb-2021, the patient experienced ILLNESS (sick all night) and MYALGIA (body aches). On 08-Feb-2021, the patient experienced COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), NAUSEA (nauseated) and VOMITING (threw up). On 09-Feb-2021, the patient experienced ASTHENIA (weak) and NECK PAIN (hurt in the back of her neck). At the time of the report, ILLNESS (sick all night), COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), ASTHENIA (weak), NECK PAIN (hurt in the back of her neck), MYALGIA (body aches), PYREXIA (fever), NAUSEA (nauseated) and VOMITING (threw up) outcome was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Pyrexia, Vomiting
Clinical narrative: weak; hurt in the back of her neck; cold sweats; feels like she was going to die; nauseated; threw up; body aches; sick all night; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick all night), COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), ASTHENIA (weak) and NECK PAIN (hurt in the back of her neck) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN A [RETINOL] and PROBIOTICS NOS for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (fever). On 06-Feb-2021, the patient experienced ILLNESS (sick all night) and MYALGIA (body aches). On 08-Feb-2021, the patient experienced COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), NAUSEA (nauseated) and VOMITING (threw up). On 09-Feb-2021, the patient experienced ASTHENIA (weak) and NECK PAIN (hurt in the back of her neck). At the time of the report, ILLNESS (sick all night), COLD SWEAT (cold sweats), FEELING ABNORMAL (feels like she was going to die), ASTHENIA (weak), NECK PAIN (hurt in the back of her neck), MYALGIA (body aches), PYREXIA (fever), NAUSEA (nauseated) and VOMITING (threw up) outcome was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Fever - As High as 101.0F; Fatigue; Swollen - Near Injection Site; Red - Near Injection Site; Hot to the Touch Sensation - Near Injection Site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever - As High as 101.0F), FATIGUE (Fatigue), INJECTION SITE SWELLING (Swollen - Near Injection Site), INJECTION SITE ERYTHEMA (Red - Near Injection Site) and INJECTION SITE WARMTH (Hot to the Touch Sensation - Near Injection Site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PYREXIA (Fever - As High as 101.0F), FATIGUE (Fatigue), INJECTION SITE SWELLING (Swollen - Near Injection Site), INJECTION SITE ERYTHEMA (Red - Near Injection Site) and INJECTION SITE WARMTH (Hot to the Touch Sensation - Near Injection Site). On 01-Feb-2021, PYREXIA (Fever - As High as 101.0F), FATIGUE (Fatigue), INJECTION SITE SWELLING (Swollen - Near Injection Site), INJECTION SITE ERYTHEMA (Red - Near Injection Site) and INJECTION SITE WARMTH (Hot to the Touch Sensation - Near Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19, UNK, UNK, UNK
Symptoms: Burning sensation, Pruritus, Rash, Urticaria
Clinical narrative: whelps have gone away; rash is all over her body and is not going away; rash all over her body, arms, face, legs, and bottom of her feet; broke out in whelps on her legs; itching is worse at night.; both her legs experienced intense burning and itching such that she could not sit still; went from her ankles to the top of her legs; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (both her legs experienced intense burning and itching such that she could not sit still), BURNING SENSATION (went from her ankles to the top of her legs), URTICARIA (whelps have gone away), URTICARIA (broke out in whelps on her legs) and PRURITUS (itching is worse at night.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products DIETHYLTOLUAMIDE (MOSQUITO GUARD) for an unknown indication, DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ALLERGY/COLD) for an unknown indication and DIPHENHYDRAMINE HYDROCHLORIDE (ITCH RELIEF) for an unknown indication.    No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DIETHYLTOLUAMIDE (MOSQUITO GUARD) (unknown route) at an unspecified dose, DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ALLERGY/COLD) (unknown route) at an unspecified dose and DIPHENHYDRAMINE HYDROCHLORIDE (ITCH RELIEF) (unknown route) at an unspecified dose. On 06-Feb-2021, the patient experienced BURNING SENSATION (both her legs experienced intense burning and itching such that she could not sit still), BURNING SENSATION (went from her ankles to the top of her legs) and PRURITUS (itching is worse at night.). On 07-Feb-2021, the patient experienced URTICARIA (broke out in whelps on her legs) and RASH (rash all over her body, arms, face, legs, and bottom of her feet). On 09-Feb-2021, the patient experienced URTICARIA (whelps have gone away) and RASH (rash is all over her body and is not going away). At the time of the report, BURNING SENSATION (both her legs experienced intense burning and itching such that she could not sit still), BURNING SENSATION (went from her ankles to the top of her legs), URTICARIA (broke out in whelps on her legs), PRURITUS (itching is worse at night.) and RASH (rash is all over her body and is not going away) outcome was unknown, URTICARIA (whelps have gone away) had resolved and RASH (rash all over her body, arms, face, legs, and bottom of her feet) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in the breast; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes in the breast) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in the breast). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in the breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment was provided.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle fatigue, Myalgia, Pain
Clinical narrative: headaches; Muscle fatigue in his leg and Back; feels like a load on the muscles; sharp pain or something weird; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (sharp pain or something weird), MUSCLE FATIGUE (Muscle fatigue in his leg and Back), MYALGIA (feels like a load on the muscles) and HEADACHE (headaches) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.  On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced MUSCLE FATIGUE (Muscle fatigue in his leg and Back). On an unknown date, the patient experienced PAIN (sharp pain or something weird), MYALGIA (feels like a load on the muscles) and HEADACHE (headaches). At the time of the report, PAIN (sharp pain or something weird), MUSCLE FATIGUE (Muscle fatigue in his leg and Back), MYALGIA (feels like a load on the muscles) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medicines were reported and no treatment medicines were given.  Patient stated he received the 2nd vaccine and reported his symptoms were worse. Patient also stated he had some lingering symptoms   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Additional information received, added events
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain, Pain in extremity, Spinal pain
Clinical narrative: Sore arm; Back pain; very sharp pain and  it felt like I cannot sit; Pain radiating up to spine; This spontaneous case was reported by a health care professional and describes the occurrence of BACK PAIN (Back pain), PAIN (very sharp pain and  it felt like I cannot sit), SPINAL PAIN (Pain radiating up to spine) and PAIN IN EXTREMITY (Sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced BACK PAIN (Back pain), PAIN (very sharp pain and  it felt like I cannot sit) and SPINAL PAIN (Pain radiating up to spine). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, BACK PAIN (Back pain), PAIN (very sharp pain and  it felt like I cannot sit), SPINAL PAIN (Pain radiating up to spine) and PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Diarrhoea
Clinical narrative: severe diarrhea; bedridden 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Amoxicillin).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days). At the time of the report, DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: skin rash post-vaccination; This spontaneous case was reported by a nurse and describes the occurrence of RASH (skin rash post-vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (skin rash post-vaccination). At the time of the report, RASH (skin rash post-vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter stated that rash began within 20 hours up to 9 days after vaccine administration.  Treatment provided: Topical steroid cream.   This case was linked to US-MODERNATX, INC.-MOD-2021-027398 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027398:Group reporting
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: cold chills; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (cold chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (cold chills). At the time of the report, CHILLS (cold chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment drug were not reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Myalgia
Clinical narrative: Felt tired; Her body ached; She slept a lot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired), MYALGIA (Her body ached) and HYPERSOMNIA (She slept a lot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced FATIGUE (Felt tired), MYALGIA (Her body ached) and HYPERSOMNIA (She slept a lot). On 20-Jan-2021, FATIGUE (Felt tired), MYALGIA (Her body ached) and HYPERSOMNIA (She slept a lot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Very tender lymphadenopathy; This spontaneous case was reported by a health care professional and describes the occurrence of LYMPHADENOPATHY (Very tender lymphadenopathy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Very tender lymphadenopathy). At the time of the report, LYMPHADENOPATHY (Very tender lymphadenopathy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  No treatment information was provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain, Vomiting
Clinical narrative: weakness; Soreness; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting), ASTHENIA (weakness) and PAIN (Soreness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VOMITING (Vomiting). On 09-Feb-2021, the patient experienced ASTHENIA (weakness) and PAIN (Soreness). On 08-Feb-2021, VOMITING (Vomiting) had resolved. At the time of the report, ASTHENIA (weakness) and PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Impaired driving ability
Clinical narrative: dizziness; kind of a headache; has not been able to drive; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (kind of a headache) and IMPAIRED DRIVING ABILITY (has not been able to drive) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Sleep disorder. Concomitant products included Norityptiline for Sleep disorder.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), HEADACHE (kind of a headache) and IMPAIRED DRIVING ABILITY (has not been able to drive). At the time of the report, DIZZINESS (dizziness), HEADACHE (kind of a headache) and IMPAIRED DRIVING ABILITY (has not been able to drive) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.